Levodopa/Carbidopa Fairmed

Medicinal product

(Invented) name

Levodopa/Carbidopa Fairmed

Active substance (s)

Levodopa/Karbidopa

Strength

100 mg/25 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N04BA02, Levodopa and decarboxylase inhibitor

Marketing authorisation holder

Fairmed Healthcare GmbH, Vokietija

Date of authorisation

2022-02-22

Date of renewal

Documents

4914_4915 Levodopa_Carbidopa Fairmed RPP 2025 01 17.docx

4914_4915 Pakuotės lapelis 2025 01 17.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

SE/H/1970/003/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Levodopa	100 mg
Karbidopa	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
108126	94230	1094230	lizdinė plokštelė	N20		Receptinis	LT/1/22/4914/001	Netiekiama	-	-	No	-	-
108127	94231	1094231	lizdinė plokštelė	N100		Receptinis	LT/1/22/4914/002	Netiekiama	-	-	No	-	-
108128	94232	1094232	lizdinė plokštelė	N200		Receptinis	LT/1/22/4914/003	Netiekiama	-	-	No	-	-
117080	103181	1103181	lizdinė plokštelė	N50		Receptinis	LT/1/22/4914/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-02-22	Registruotas